Literature DB >> 17203997

Characterization of monoclonal antibodies to human soluble MD-2 protein.

Suganya Viriyakosol1, Paul B McCray, Mark E Ashbaugh, Jayne Chu, Hong Peng Jia, Jerold Weiss, Theo N Kirkland.   

Abstract

Toll-like receptors (TLRs) are mammalian innate immune recognition receptors that are activated by pathogen associated molecular patterns (PAMPs). TLR4 is the signaling molecule of the lipopolysaccharide (LPS) receptor complex. TLR4 associates with its adapter molecule, MD-2, which is absolutely required for LPS-induced activation of TLR4. MD-2 exists as a cell surface protein in association with TLR4 and as secreted forms consisting of MD-2 monomers and multimers. To facilitate the studies of MD-2 distribution, abundance, and function, we produced monoclonal antibodies (MAbs) to baculovirally expressed soluble MD-2 (sMD-2). Eleven MAbs were characterized by enzyme-linked immunosorbent assay (ELISA) with soluble TLR4/MD-2 complex (sTLR4/MD-2) and sMD-2, Western blotting against sMD-2 monomer and multimers, and inhibition of direct LPS binding to sMD-2. Four MAbs preferentially recognized mainly MD-2 oligomers, not monomers, as judged by Western blotting and ELISA. Anti-MD-2 MAbs useful for indirect immunofluorescent staining of cells expressing TLR4 and MD-2 were identified. One MAb that recognized all forms of MD-2 was used in an ELISA to measure sMD-2 in normal human sera as well as sera from intensive care patients with and without sepsis. Serum levels of sMD-2 were undetectable or very low in normal and in nonsepsis patients but significantly (p < 0.05) increased in sepsis patients. These MAbs should therefore be very useful new tools for studies of MD-2 expression and function in health and disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17203997     DOI: 10.1089/hyb.2006.25.349

Source DB:  PubMed          Journal:  Hybridoma (Larchmt)        ISSN: 1554-0014


  7 in total

1.  Morphine activates neuroinflammation in a manner parallel to endotoxin.

Authors:  Xiaohui Wang; Lisa C Loram; Khara Ramos; Armando J de Jesus; Jacob Thomas; Kui Cheng; Anireddy Reddy; Andrew A Somogyi; Mark R Hutchinson; Linda R Watkins; Hang Yin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

Review 2.  Alcoholic liver disease and the gut-liver axis.

Authors:  Gyongyi Szabo; Shashi Bala
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

3.  Phagocytosis and intracellular killing of MD-2 opsonized gram-negative bacteria depend on TLR4 signaling.

Authors:  Vishal Jain; Annett Halle; Kristen A Halmen; Egil Lien; Marie Charrel-Dennis; Sanjay Ram; Douglas T Golenbock; Alberto Visintin
Journal:  Blood       Date:  2008-01-18       Impact factor: 22.113

4.  Identification of single nucleotide polymorphisms in hematopoietic cell transplant patients affecting early recognition of, and response to, endotoxin.

Authors:  Eva C Guinan; Christine D Palmer; Christy J Mancuso; Lisa Brennan; Liat Stoler-Barak; Leslie A Kalish; Eugenie E Suter; Leighanne C Gallington; David P Huhtelin; Maria Mansilla; Ralf R Schumann; Jeffrey C Murray; Jerrold Weiss; Ofer Levy
Journal:  Innate Immun       Date:  2013-10-09       Impact factor: 2.680

5.  Free thiol group of MD-2 as the target for inhibition of the lipopolysaccharide-induced cell activation.

Authors:  Mateja Mancek-Keber; Helena Gradisar; Melania Iñigo Pestaña; Guillermo Martinez de Tejada; Roman Jerala
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

6.  Isolation of monomeric and dimeric secreted MD-2. Endotoxin.sCD14 and Toll-like receptor 4 ectodomain selectively react with the monomeric form of secreted MD-2.

Authors:  Athmane Teghanemt; Richard L Widstrom; Theresa L Gioannini; Jerrold P Weiss
Journal:  J Biol Chem       Date:  2008-06-02       Impact factor: 5.157

7.  Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties.

Authors:  Florent Cochet; Fabio A Facchini; Lenny Zaffaroni; Jean-Marc Billod; Helena Coelho; Aurora Holgado; Harald Braun; Rudi Beyaert; Roman Jerala; Jesus Jimenez-Barbero; Sonsoles Martin-Santamaria; Francesco Peri
Journal:  Sci Rep       Date:  2019-01-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.